Noncosmetic uses of botulinum toxin

被引:18
作者
Bentsianov, B
Zalvan, C
Blitzer, A
机构
[1] New York Ctr Voice & Swallowing Disorders, New York, NY 10019 USA
[2] New York Med Coll, Valhalla, NY 10595 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY USA
关键词
D O I
10.1016/j.clindermatol.2003.12.030
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Since the introduction of botulinum toxin (BTX) as a therapeutic tool in the 1970s, the number of uses for this substance has increased exponentially. BTX's mechanism of action involves degrading the SNARE proteins blockading the release of acetylcholine into the neuromuscular junction. In many body systems, decrease of contractility, strength, and tension of certain muscle groups result in improved clinical outcomes. Applications now include cosmetic, gastroenterologic, otolaryngologic, genitourinary, neurologic, and dermatologic uses. In fact, BTX can be considered as a potential treatment in any situation involving inappropriate or exaggerated muscle contraction. Currently, the FDA has approved BTX-A (Botox) for treating glabellar lines, blepharospasm, strabismus, hemifacial spasm, cervical dystonia, and spasticity. With the addition of cosmetic applications to the FDA's approval list, the use of BTX has increased dramatically.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 86 条
[1]  
AKKOC Y, 2000, BJU INT, V86, P754
[2]   Botulinum toxin treatment for symptomatic Frey's syndrome [J].
Arad-Cohen, A ;
Blitzer, A .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (02) :237-240
[3]   Botulinum toxin treatment of muscle cramps: A clinical and neurophysiological study [J].
Bertolasi, L ;
Priori, A ;
Tomelleri, G ;
Bongiovanni, LG ;
Fincati, E ;
Simonati, A ;
DeGrandis, D ;
Rizzuto, N .
ANNALS OF NEUROLOGY, 1997, 41 (02) :181-186
[4]   Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study [J].
Binder, WJ ;
Brin, MF ;
Blitzer, A ;
Schoenrock, LD ;
Pogoda, JM .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 123 (06) :669-676
[5]  
Blitzer A, 1995, OTOLARYNG HEAD NECK, V113, P668
[6]  
Blitzer A, 1997, OTOLARYNG HEAD NECK, V116, P328
[7]   Botulinum toxin management of spasmodic dysphonia (Laryngeal dystonia): A 12-year experience in more than 900 patients [J].
Blitzer, A ;
Brin, MF ;
Stewart, CF .
LARYNGOSCOPE, 1998, 108 (10) :1435-1441
[8]   BOTULINUM TOXIN INJECTION FOR THE TREATMENT OF OROMANDIBULAR DYSTONIA [J].
BLITZER, A ;
GREENE, PE ;
BRIN, MF ;
FAHN, S .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1989, 98 (02) :93-97
[9]   BOTULINUM TOXIN INJECTIONS FOR LINGUAL DYSTONIA [J].
BLITZER, A ;
BRIN, MF ;
FAHN, S .
LARYNGOSCOPE, 1991, 101 (07) :799-799
[10]  
BLITZER A, 2002, SCI THER ASPECTS BOT